Evidence map›Paper›PMID 35844611›Full record

ArticleFrontiers in immunology2022

Therapeutic Potential of Photosynthetic Microorganisms for Visceral Leishmaniasis: An Immunological Analysis.

Victor Vaitkevicius-Antão, Jady Moreira-Silva, Isabelle Barreto da Silva Moreira Reino, Maria Gabriella Nunes de Melo, José Noé da Silva-Júnior, Alexsandra Frazão de Andrade, Paulo Sérgio Ramos de Araújo, Raquel Pedrosa Bezerra, Daniela de Araújo Viana Marques, Silvana Ferreira and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Research in pharmaceutical sciences · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Victor Vaitkevicius-AntãoDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Jady Moreira-SilvaDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Isabelle Barreto da Silva Moreira ReinoDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Maria Gabriella Nunes de MeloDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
José Noé da Silva-JúniorResearch Support Center, Federal Rural University of Pernambuco, Recife, Brazil.
Alexsandra Frazão de AndradeResearch Support Center, Federal Rural University of Pernambuco, Recife, Brazil.
Paulo Sérgio Ramos de AraújoDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Raquel Pedrosa BezerraResearch Support Center, Federal Rural University of Pernambuco, Recife, Brazil.
Daniela de Araújo Viana MarquesInstitute of Biological Sciences, University of Pernambuco, Recife, Brazil.
Silvana FerreiraInstitute of Biological Sciences, University of Pernambuco, Recife, Brazil.
Rômulo Pessoa-E-SilvaCentral Public Health Laboratory of Pernambuco, Endemics Laboratory, Recife, Brazil.
Virginia Maria Barros de LorenaDepartment of Immunology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Milena de Paiva-CavalcantiDepartment of Microbiology, Aggeu Magalhães Institute, Fiocruz Pernambuco, Recife, Brazil.
Fundação Oswaldo Cruz · BRUniversidade Federal Rural de Pernambuco · BRUniversidade de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New therapeutic strategies for visceral leishmaniasis (VL) have been studied, and the development of an immunotherapeutic agent that modulates the host's immune response is necessary. The aim of this study was to evaluate

Indexed as

Antiprotozoal AgentsLeishmaniasis, VisceralAnimalsCytokinesHumansLeukocytes, MononuclearMiceMice, Inbred BALB CAntiprotozoal AgentsCytokinescyanobacteriaimmunomodulationLeishmania infantummicroalgaetherapy

Identifiers

PMID35844611
PMCPMC9280147
OpenAlexW4283750985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.